Zitierte Werke - Lkc Technologies Reteval Benutzerhandbuch

Zitierte Werke

Zitierte Werke
Ahmadi, M, and Q Q Rodrigo. 2013. "Automatic denoising of single-trial evoked potentials."
NeuroImage:672-680.
Audo, I., M. Michaelides, A. G. Robson, M. Hawlina, V. Vaclavik, J. M. Sandbach, M. M.
Neveu, C. R. Hogg, D. M. Hunt, A. T. Moore, A. C. Bird, A. R. Webster, and G. E.
Holder. 2008. "Phenotypic variation in enhanced S-cone syndrome." Invest
Ophthalmol Vis Sci 49 (5): 2082-93. doi: 10.1167/iovs.05-1629.
Berson, EL. 1993. "Retinitis pigmentosa: The Friedenwald Lecture." Investigative
Ophthalmology and Visual Science 34:1659-1673
Brigell, M. G., B. Chiang, A. Y. Maa, and C. Q. Davis. 2020. "Enhancing Risk Assessment in
Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and
Structure." Transl Vis Sci Technol 9 (9):40. doi: 10.1167/tvst.9.9.40.
Centers for Disease Control and Prevention. 2011. National Diabetes Fact Sheet, 2011.
edited by US Department of Health and Human Services, Centers for Disease Control
and Prevention.
Cideciyan, A, and S Jacobson. 1996. "An alternative phototransduction model for human rod
and cone ERG a-waves: normal parameters and variation with age." Vision Res:2609-
21
Cideciyan, A. V., and S. G. Jacobson. 1993. "Negative electroretinograms in retinitis
pigmentosa." Invest Ophthalmol Vis Sci 34 (12):3253-63.
CLSI. 2008. Guideline for Defining, Establishing, and Verifying Reference Intervals in the
Clinical Laboratory; Approved Guideline—Third Edition. CLSI Document EP28-A3c.
Wayne, PA: Clinical and Laboratory Standards Institute.
Davis, C. Q., and R. Hamilton. 2021. "Reference ranges for clinical electrophysiology of
vision." Doc Ophthalmol. doi: 10.1007/s10633-021-09831-1.
Davis, C. Q., O. Kraszewska, and C. Manning. 2017. "Constant luminance (cd.s/m2) versus
constant retinal illuminance (Td.s) stimulation in flicker ERGs." Doc Ophthalmol. doi:
10.1007/s10633-017-9572-3.
Davis, M. D., M. R. Fisher, R. E. Gangnon, F. Barton, L. M. Aiello, E. Y. Chew, F. L. Ferris, 3rd,
and G. L. Knatterud. 1998. "Risk factors for high-risk proliferative diabetic
retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study
Report #18." Invest Ophthalmol Vis Sci 39 (2):233-52.
Degirmenci, M. F. K., S. Demirel, F. Batioglu, and E. Ozmert. 2018. "Role of a mydriasis-free,
full-field flicker ERG device in the detection of diabetic retinopathy." Doc
Ophthalmol 137 (3): 131-141. doi: 10.1007/s10633-018-9656-8.
FDA Advisory Committee. 2009. Sabril® (vigabatrin) for Oral Solution for Infantile Spasms.
Fishman, G A, D G Birch, G E Holder, and M G Brigell. 2001. Electrophysiologic Testing: The
Foundation of the American Academy of Ophthalmology.
RETeval Geräte-Benutzerhandbuch 81